Form D · Other Health Care

AMSURG CORP

Nashville, TN · CIK 0000895930

Offering snapshot reported Jul 22, 2014 · SEC filing

Reported sold
$271M
Offering amount: $271M
Investors reported
130
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 16, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 22, 2014Initial$270,902,323No comparison130SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-221580

Source: Form D, filed Jul 22, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas G. Cigarran Director
Phillip A. Clendenin Executive
James A. Deal Director
Kevin D. Eastridge Executive
Steven I. Geringer Director
Claire M. Gulmi Director, Executive
Henry D. Herr Director
Christopher A. Holden Director, Executive
Joey A. Jacobs Director
Christopher R. Kelly Executive
Kevin P. Lavender Director
David L. Manning Executive
Cynthia S. Miller Director
John W. Popp, Jr., M.D. Director
Shawn G. Strash Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
20 Burton Hills Blvd. Suite 500
Nashville, TN, 37215